Tag: Inflectra

As of early 2023, the U.S. FDA had approved multiple biosimilars for infliximab, the active ingredient in Remicade, creating more options for patients. To answer, “What is the sister drug to Remicade?”, one must understand that as a biologic medication, Remicade's "sisters" are not identical generics but are instead highly similar, equally effective products called biosimilars.

First approved in 1998 for Crohn's disease, Remicade (infliximab) was the first biologic of its kind but is no longer the only option. When asking, 'What is the new name for Remicade?', the answer is not a single product, but rather a number of FDA-approved biosimilars and a subcutaneous alternative.